Early Detection Matters: Strengthening Referral Pathways for MAFLD and Liver Disease Detection
Putting the GESA and ADS MAFLD Guidelines into Action
MEET OUR PRESENTER
Professor Emmanouil Tsochatzis is a Professor of Hepatology and Honorary Consultant at the UCL Institute for Liver and Digestive Health in the Royal Free Hospital and head of the Centre for Metabolic Liver Diseases in ILDH. He leads the specialist multidisciplinary service in NAFLD and has an active research program. His clinical interests include NAFLD, non-invasive fibrosis assessment, cirrhosis and portal hypertension and metabolic liver disease including wilson’s disease and iron disorders.
Professor Tsochatzis finished his specialty training and PhD in Hippokration General Hospital in Greece, before moving to the Royal Free Hospital for his post-doc research. He has been a consultant hepatologist and a clinical academic since 2014. Since 2019, he has been a member of the scientific committee and governing board of EASL.
He sits on national and international clinical guideline committees, serves as specialist advisor to NICE, and is actively involved in undergraduate and postgraduate education. He is a member of the steering committee of the Baveno collaboration for portal hypertension. He has led several international research collaborations resulting in more than 230 publications in peer reviewed journals. He has designed pathways for risk stratification of patients with liver disease in primary care and is passionate on improving the outcomes of patients with liver disease. He has received funding for his research from NIHR, EASL and EU Horizon 2020.
When not working, he enjoys reading and spending time with his young family.
Professor James O’Beirne MBBS (Hons) MD FRACP FRCP EDIC
Prof. O’Beirne is a Consultant Hepatologist at the Sunshine Coast University Hospital.
He trained in Hepatology in the UK and was appointed as a Consultant Transplant Hepatologist at the Royal Free Hospital, London in 2007. Prof. O’Beirne relocated to Australia in 2017 to help develop the hepatology service at Sunshine Coast University Hospital.
Prof. O’Beirne is active in commercial and investigator led clinical studies in all aspects of hepatology. He is a member of the GESA liver faculty and the Baveno cooperation. He is currently hepatology editor for the IMJ and Associate editor for Frontline Gastroenterology.
These webinar broadcasts are supported by an independent educational sponsorship from NovoNordisk. Statements, conclusions and opinions reflect the presenter’s point of view only, and not that of the companies.
